Warrant Compensation Sample Clauses

Warrant Compensation. In consideration of the services to be provided for hereunder, the Company shall pay to the Placement Agent or its respective designees at the Initial Closing Date and each Additional Closing Date, if any, warrants (“Placement Agent Warrants”) for the purchase of an aggregate of a number of shares of Common Stock (the “Placement Agent Warrant Shares”), representing four percent (4%) of the Placement Securities sold at such Closing Date. The Placement Agent Warrants, in the form of Exhibit C hereto, shall be exercisable, in whole or in part, expiring on the five-year anniversary of the date of this Agreement at an initial exercise price per share of Common Stock of $4.10. Delivery of the Placement Agent Warrants shall be made at the relevant Closing Date, and shall be issued in the name or names and in such authorized denominations as the Placement Agent may request.

Warrant Compensation. Except as described in Section 3(e), Iridium shall compensate Motorola for incurring the Motorola Exposure by issuing warrants (the "Warrants") to purchase Class 1 Interests in Iridium ("Shares")

Warrant Compensation. Upon execution of this Agreement, the Company shall issue 250,000 warrants, subject to vesting requirements as set forth, to Employee entitling Employee to purchase non-callable no par voting common stock of the Company. Each warrant shall entitle the holder thereof to purchase one share of common stock as follows: 5 years $ 2.00 30,000 Immediately 5 years $ 2.00 30,000 One Year 5 years $ 2.00 30,000 Two Years 5 years $ 2.00 30,000 Three Years 5 years $ 2.00 30,000 Four Years 5 years $ 3.00 6,666 Immediately 5 years $ 3.00 6,666 One Year 5 years $ 3.00 6,666 Two Years 5 years $ 3.00 6,666 Three Years 5 years $ 3.00 6,669 Four Years 5 years $ 4.00 6,666 Immediately 5 years $ 4.00 6,666 One Year 5 years $ 4.00 6,666 Two Years 5 years $ 4.00 6,666 Three Years 5 years $ 4.00 6,669 Four Years * Length of time after the effective date. 5 years $ 5.00 5,555 Immediately 5 years $ 5.00 5,555 One Year 5 years $ 5.00 5,555 Two Years 5 years $ 5.00 5,555 Three Years 5 years $ 5.00 5,559 Four Years * Length of time after the effective date. Subject to the vesting provisions above, the warrants may be exercised from the Effective Date until 11:59 p.m. (San Francisco time) on the date that is five years after the date of this Agreement. Each warrant not exercised on or before the expiration date shall expire. The no par voting common shares issued pursuant to the warrant exercises shall be identical in all respects to the currently outstanding no par common of the Company. The Company shall include the shares of common stock reserved for issuance under the above-described warrants in any registration statement it files during the Employment Term, subject to any limitations imposed by an underwriter on the amount of such shares that can be included in such registration, and Employee shall be subject to all lock-ups (restricting his resale rights) imposed by the underwriter on the Company’s other management shareholders. Employee shall also be entitled to participate annually in any incentive stock option plan (“Plan”) adopted by the Company and in effect during the year(s) Employee is employed by the Company. Compensation received as a result of participation in a Plan adopted by the Company shall be referred to as the “Incentive Compensation.” Incentive Compensation shall be determined at the sole discretion of the President.

Warrant Compensation. The Company shall issue PA, as the remainder of the compensation for the services provided by PA hereunder, a warrant (the “Warrant Fee” and with the Cash Fee, collectively, the “Fee”) in the form of the Warrant Agreement attached as Exhibit D. The Warrant Agreement will be exercisable for that number of shares of Common Stock of the Company equal to the product of the number of shares of Preferred Shares sold in the Financing to Qualified Investors and 0.05. In order for shares to be considered sold under this Section 2(b), the Company or its designated agent must have accepted possession of the applicable investment funds.

Warrant Compensation. In consideration of the services to be provided for hereunder, the Company shall pay to the Placement Agent or its respective designees at the Initial Closing Date and each Additional Closing Date, if any, warrants (“Agent Warrants”) for the purchase of an aggregate of a number of shares of Common Stock (the “Agent Warrant Shares”), representing 5.0% of the Placement Securities sold at such Closing Date. The Agent Warrants, in the form of Exhibit B hereto, shall be exercisable, in whole or in part, commencing on the date that is 180 days after the date of this Agreement and expiring on the five-year anniversary of the date of this Agreement at an initial exercise price per share of Common Stock of $1.125. The Placement Agent understands and agrees that there are significant restrictions pursuant to FINRA Rule 5110 against transferring the Agent Warrants and the Agent Warrant Shares during the one hundred eighty (180) days after this Agreement and by its acceptance thereof shall agree that it will not sell, transfer, assign, pledge or hypothecate the Agent Warrants, or any portion thereof, or be the subject of any hedging, short sale, derivative, put or call transaction that would result in the effective economic disposition of such securities for a period of one hundred eighty (180) days following the date of this Agreement to anyone other than (i) a sub-agent or selected-dealer in connection with the Placement or (ii) a bona fide officer, partner, employee or registered representative of the Placement Agent, sub-agent or selected-dealer; and only if any such transferee agrees to the foregoing lock-up restrictions. Delivery of the Agent Warrants shall be made at the relevant Closing Date, and shall be issued in the name or names and in such authorized denominations as the Placement Agent may request.

Warrant Compensation. The Company shall issue PA, as the remainder of the compensation for the services provided by PA hereunder, a warrant (the “Warrant Fee” and with the Cash Fee, collectively, the “Fee”) in the form of the Warrant Agreement attached as Exhibit D. The Warrant Agreement will be exercisable for that number of shares of Series G Preferred Stock equal to the product of: (i) the excess of the number of shares of Series G Preferred Stock sold in the Financing to Qualified Investors over 333,333, and (ii) (u) 0.05 for shares sold on or before January 15, 2005, (v) 0.04 for shares sold after January 15, 2005 but on or before January 22, 2005, (w) 0.03 for shares sold after January 22, 2005 but on or before January 29, 2005, (x) 0.02 for shares sold after January 29, 2005 but on or before February 5, 2005, (y) 0.01 for shares sold after February 5, 2005 but on or before February 12, 2005 and (z) 0.00 for shares sold after February 12, 2005. In order for shares to be considered sold under this Section 2(b) by a certain date, the Company or its designated agent must have accepted possession of the applicable investment funds by that date. In the event Company accepts investments (including (i) the applicable funds from each investor; (ii) signature pages to all the financing agreements and any amendments from each investor; and (iii) suitability questionnaire for each investor that provide each such investor’s principal place of business and accredited status) in the Financing pursuant to Section 1(b) from Qualified Investors who have committed subscriptions in the aggregate amount of $5 million or more by January 15, 2005, January 22, January 29, February 5 or February 12, 2005, as the case may be, but the Company elects to close on such investments after January 15, 2005, January 22, January 29, February 5 or February 12, 2005, respectively, PA will nevertheless be entitled to receive the warrant coverage set forth in the preceding sentence for the prior period on such portion of such investment amount if and when the Company closes on such investment.

Warrant Compensation. The Placement Agent shall receive additional compensation in the form of warrants (“Placement Agent Warrants”) issuable to Westminster Securities Corp. or its designees to purchase shares of Common Stock, in an amount equal to four percent (4%) of the total number of shares of Common Stock underlying Units sold in the Offering, exercisable at the price per share of the Shares. The Placement Agent Warrants and the shares of Common Stock issuable upon exercise of the Placement Agent Warrants shall have piggy-back registration, anti-dilution and other rights as disclosed in the Transaction Documents, and shall be exercisable any time from the initial Closing Date until the third anniversary thereof. Warrant compensation shall be paid in full within thirty (30) days of the final Closing Date with respect to the total Units sold in the Offering.

Warrant Compensation. In addition to the Advisory Fee, Post Success Services (if applicable), and Success Fee (if applicable), in exchange for the Services, Client shall issue to ▇▇▇▇ ▇▇▇▇▇▇ (“▇▇▇▇▇▇”) warrants to purchase restricted shares of the common stock, $0.0001 par value per share (the “Common Stock”), of the Client (the “Warrants”) as set forth below: (i) 1,250,000 Warrants (the “Initial Warrants”) issued as of the date of execution of this Agreement, that immediately vest, and (ii) and an additional one time issuance of up to 2,000,000 Warrants (the “Additional Warrants”) issued upon the closing of an acquisition by Client of any medical or retail marijuana license and issuance of such license or the closing of an acquisition of an established medical or retail marijuana operation or closing of a successful Business Combination in the Cannabis Industry directly introduced to the Client by either Santus or Lotus (the “Opportunities”), provided that Santus will only be entitled to the Additional Warrants if the minimum value of such Opportunities aggregates to at least $2,000,000. For the avoidance of doubt, Lotus shall only be entitled to a maximum of 2,000,000 Additional Warrants irrespective of how many such opportunities are consummated by Client. Each Initial Warrant shall be a 3-year warrant to purchase one share of Common Stock at an exercise price of $0.01 per share (subject to equitable adjustment in the event of any stock dividend, stock split, stock combination, recapitalization, reclassification, reorganization or other similar event pertaining to the Common Stock), and except as set forth herein, the terms of the Warrants shall be in the form of standard warrants issued to consultants of the Client, except that the Warrants can be exercised on a cashless basis and shall be exercisable for a period of three (3) years from the date of issuance. The Warrants shall be issued in the name of Santus or certain affiliates of Santus by delivery of instructions to the Company providing for the names of designees who are affiliates of Santus. (ii) Santus represents and warrants to the Company that, as of the date hereof and the time of such issuance, he (i) will acquire the Warrants and if exercised, the shares of Common Stock underlying the Warrants (the “Shares”), for investment for his own account and not with the view to, or for resale in connection with, any distribution thereof; (ii) understands and acknowledges that the Warrants and the Shares have not been reg...

Warrant Compensation. On the Effective Date, the Company will execute and deliver to the Consultant stock purchase warrants (the "Consulting Warrants") giving the Consultant the right upon exercise thereof to purchase 487,500 shares of the Company's Common Stock. The Consulting Warrants shall be exercisable upon issuance and shall expire five years after issuance by the Company and shall be in the form attached hereto as Exhibit A. The exercise price of the Consulting Warrants shall be determined as follows: (i) if, on or before March 1, 1999, the Company consummates any of the following (a "Qualifying Corporate Transaction"): (a) a merger with the Park Group, Ltd. (the "Proposed Park Group Merger"). (b) another transaction ("Other Transaction"), pursuant to which a class of equity securities of the Company or its successor becomes registered under Section 12 of the Securities Act of 1934, as amended (the "Exchange Act"), and the Company becomes obligated to file periodic reports under Section 13 of the Exchange Act. then the exercise price per share shall be $4.0 million divided by the number of shares of the Company's common stock outstanding after completion of the Qualifying Corporate Transaction. (ii) prior to the completion of a Qualifying Corporate Transaction and, if a Qualifying Corporate Transaction is not consummated by March 1, 1999, then, after March 1, 1999, the exercise price shall be $1.00 per share. If the Company completes a Qualifying Corporate Transaction pursuant to which a class of equity securities of the Company or its successor becomes registered under Section 12 of the Exchange Act, and the Company becomes obligated to file periodic reports under Section 13 of the Exchange Act, then the Company will file a registration statement to register the resale of the shares of common stock issuable upon exercise of the Consulting Warrants, in accordance with the Consulting Warrant attached hereto as Exhibit A, on the earlier of (x) three months following the date of completion of the Qualifying Corporate Transaction, or (y) the first date on which the Company may file such a registration statement in accordance with all applicable State and Federal securities laws. If within one year from the date of this Agreement, the Company has not completed a Qualifying Corporate Transaction, then the Consultant and his assigns shall be entitled to receive (i) a special semi-annual dividend for a period of seven years or until the Company completes a Qualifying Corporate T...